Ascom Acquires the Italian Medical Software Company UMS

AscomAscom has acquired the Italian software company UMS (United Medical Software), which provides integrations for medical devices and supplies digital medical records software solutions for life-critical patient care. With the acquisition of UMS, Ascom will gain access to new software and competence for global integrated workflow solutions in Healthcare ICT. Moreover, Ascom will improve its market position in Italy significantly thanks to the UMS installed base.

UMS s.r.l. is a privately held medical software company based in the region of Florence. The company delivers modular, point-of-care, digital medical records software solutions for life-critical patient care. UMS solutions help clinicians treat patients facing life-critical outcomes, while filing the gaps in digital medical records technology. UMS offers more than 200 medical device integrations and 1,000 different EMR forms and integrations. UMS' customers include large university hospitals, private specialty clinics, and healthcare government entities. UMS has products ready for international deployment and installations in Europe. The Company produces CE-marked medical device software, and is a partner/supplier of large companies in the medical device business.

UMS has a well-established installed base, mainly in the Italian market, and is expected to achieve revenues in the range of EUR 3-4 million in 2015, with EBITDA margins comparable to the Ascom Wireless Solutions Division.

With this acquisition, Ascom will gain access to new software and additional competence for global integrated workflow solutions in Healthcare ICT. Ascom will leverage the acquired software solutions globally. Consequently, capabilities to integrate medical devices and therefore mission-critical data into existing Ascom workflow solutions and Ascom Myco will be increased. In addition, Ascom will be granted access to new solutions for intensive care and surgical workflow management in high acuity units. Finally, the acquisition will help Ascom reach previously underserved geographical areas and increase its market share in Italy and Southern Europe. The acquisition fits perfectly with Ascom’s strategy for achieving its 2020 ambitions.

Ascom signed an agreement to acquire all shares of the company UMS s.r.l. Closing is expected to take place in mid-January 2016. All 27 employees will be taken over at their existing location. The purchase price amounts to the mid-single digit millions in CHF. In addition, Ascom has agreed to an earn-out payment in the low-single digit millions in CHF, dependent on the achievement of agreed revenue targets.

Gabriele Unterberger, who founded and successfully led UMS, will continue to run the company, to be renamed "Ascom UMS s.r.l.", as its Managing Director.

"Ascom is very pleased to have acquired a business with such a good strategic fit. This is an important technology acquisition for Ascom’s Healthcare ICT strategy. With the acquired software solutions, we have the opportunity to give our customers even more possibilities to improve their clinical workflows. In addition, we will gain direct access to the Italian market. This transaction accelerates Ascom’s roadmap for its integration capabilities and is the next step in building and strengthening the leading position of Wireless Solutions in the global healthcare communications market," underlines Claes Ödman, General Manager Ascom Wireless Solutions.

About Ascom
Ascom is an international solutions provider with comprehensive know-how in healthcare workflows and telecommunications. The company is active in Wireless Solutions (an international market leader for high-value, customer-specific on-site communication solutions and workflow optimization) and Network Testing (a global market leader in testing, monitoring, post processing, and performance optimization for mobile networks). The Ascom Group is headquartered in Switzerland, has subsidiaries in 19 countries and employs around 1,700 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...